UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934.
Date of Report: November 2, 2017
(Date of earliest event reported)
BioVie Inc.
(Exact name of registrant as specified in its charter)
| Nevada | 333-190635 | 46-2510769 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification Number) | ||
| 100 Cummings Center, Suite 247-C, Beverly, MA | 01915 | |||
| (Address of principal executive offices) | (Zip Code) | |||
(312) 283-5793
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02(d) Election of Directors.
On November 2, 2017, the Board of Directors of BioVie Inc. (the "Company") elected Mina Sooch as an independent member of the Company’s Board of Directors. Ms. Sooch is an experienced and accomplished biopharmaceutical executive with over 25 years of experience in the life sciences sector, with significant experience as a venture capitalist.
There are no family relationships between Ms. Sooch and any director or other executive officer of the Company nor are there any transactions between Ms. Sooch or any member of her immediate family and the Company or any of its subsidiaries that would be reportable as a related party transaction under the rules of the United States Securities and Exchange Commission. Further, there is no arrangement or understanding existing between Ms. Sooch and any other persons or entities pursuant to which Ms. Sooch was selected as a directory of the Company.
-1-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Dated: November 7, 2017 | BIOVIE INC. | ||||||||
| By: | /s/ Jonathan Adams | ||||||||
| Jonathan Adams | |||||||||
| Chief Executive Officer | |||||||||
-2-